CapMan has redefined its financial objectives and revised vision, mission and values. CapMan’s financial objectives include average capital growth of funds under management of at least 15% per annum and equity fund performance above 15% net IRR to fund investors per annum.
Company has raised €20m so far over two funding rounds
HV Holtzbrinck and Lakestar also participate in the round for the dental technology startup
IK VIII held a final close in November 2016 with €1.85bn and was 87% deployed as of December 2019
With the GP's support, Bomi intends to pursue an intensive buy-and-build strategy